Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection
Clinical trial NCT04811040 · COMPLETED
Trial details
- NCT number
- NCT04811040
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-08
- Primary completion
- 2022-06-09
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.